| Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015 | 1207 | 2015 |
| IL-2, regulatory T cells, and tolerance BH Nelson The Journal of Immunology 172 (7), 3983-3988, 2004 | 822 | 2004 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (6), 311-335, 2017 | 725 | 2017 |
| Neo-antigens predicted by tumor genome meta-analysis correlate with increased patient survival SD Brown, RL Warren, EA Gibb, SD Martin, JJ Spinelli, BH Nelson, ... Genome research 24 (5), 743-750, 2014 | 684 | 2014 |
| Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology … S Hendry, R Salgado, T Gevaert, PA Russell, T John, B Thapa, M Christie, ... Advances in anatomic pathology 24 (5), 235-251, 2017 | 648 | 2017 |
| Biology of the interleukin-2 receptor BH Nelson, DM Willerford Advances in immunology 70, 1-81, 1998 | 636 | 1998 |
| RETRACTED: Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death L Van Parijs, Y Refaeli, JD Lord, BH Nelson, AK Abbas, D Baltimore Immunity 11 (3), 281-288, 1999 | 572 | 1999 |
| CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian … JS Nielsen, RA Sahota, K Milne, SE Kost, NJ Nesslinger, PH Watson, ... Clinical cancer research 18 (12), 3281-3292, 2012 | 563 | 2012 |
| The prognostic value of FoxP3+ tumor-infiltrating lymphocytes in cancer: a critical review of the literature RJ deLeeuw, SE Kost, JA Kakal, BH Nelson Clinical Cancer Research 18 (11), 3022-3029, 2012 | 529 | 2012 |
| Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers W Scheper, S Kelderman, LF Fanchi, C Linnemann, G Bendle, ... Nature medicine 25 (1), 89-94, 2019 | 522 | 2019 |
| Profiling the T-cell receptor beta-chain repertoire by massively parallel sequencing JD Freeman, RL Warren, JR Webb, BH Nelson, RA Holt Genome research 19 (10), 1817-1824, 2009 | 512 | 2009 |
| Tumor-infiltrating plasma cells are associated with tertiary lymphoid structures, cytolytic T-cell responses, and superior prognosis in ovarian cancer DR Kroeger, K Milne, BH Nelson Clinical Cancer Research 22 (12), 3005-3015, 2016 | 497 | 2016 |
| CD20+ B cells: the other tumor-infiltrating lymphocytes BH Nelson The Journal of Immunology 185 (9), 4977-4982, 2010 | 492 | 2010 |
| Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors K Milne, M Köbel, SE Kalloger, RO Barnes, D Gao, CB Gilks, PH Watson, ... PloS one 4 (7), e6412, 2009 | 469 | 2009 |
| Tumor-infiltrating lymphocytes expressing the tissue resident memory marker CD103 are associated with increased survival in high-grade serous ovarian cancer JR Webb, K Milne, P Watson, RJ DeLeeuw, BH Nelson Clinical cancer research 20 (2), 434-444, 2014 | 449 | 2014 |
| Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer NR West, K Milne, PT Truong, N Macpherson, BH Nelson, PH Watson Breast cancer research 13, 1-13, 2011 | 448 | 2011 |
| Cancer stemness, intratumoral heterogeneity, and immune response across cancers A Miranda, PT Hamilton, AW Zhang, S Pattnaik, E Becht, A Mezheyeuski, ... Proceedings of the National Academy of Sciences 116 (18), 9020-9029, 2019 | 418 | 2019 |
| Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation BH Nelson, JD Lord, PD Greenberg Nature 369 (6478), 333-336, 1994 | 410 | 1994 |
| Prognostic significance of tumor-infiltrating B cells and plasma cells in human cancer MCA Wouters, BH Nelson Clinical Cancer Research 24 (24), 6125-6135, 2018 | 396 | 2018 |
| Oncolytic viruses as engineering platforms for combination immunotherapy K Twumasi-Boateng, JL Pettigrew, YYE Kwok, JC Bell, BH Nelson Nature Reviews Cancer 18 (7), 419-432, 2018 | 382 | 2018 |
Julie S. NielsenLeader, Cell Manufacturing, BC Cancer's Immunotherapy ProgramVerified email at bccancer.bc.ca
